Current Study Offers Window into Automation & Outsourcing Practices within Top Pharmaceutical Market Research Groups
CHAPEL HILL, N.C. – February 27, 2012. In an effort to maximize business impact and improve efficiency with limited resources, pharma and biotech market research leaders must constantly evaluate the manner in which they outsource their labor. More specifically, executives need to understand the optimal balance of external contract employees in order to reduce redundancy and enhance productivity in the quickly changing healthcare industry.
To identify innovative strategies and approaches for maximizing market research efficiency through the use of outsourced labor and process automation, Best Practices, LLC, a world-leader in biopharmaceutical benchmarking research, has launched an exciting new study called “Using Outsourced Personnel and Automation to Maximize Market Research Efficiency.”
Preliminary results from this ongoing study suggest that outsourced labor for secondary report preparation – as compared to other key market research areas – will increase the most in the next 2-3 years. Best Practices is also monitoring additional emerging data trends around time spent managing outsourced personnel and leading processes for enhancing the impact of offsite personnel.
Study topics include:
- Outsourcing Profile
- Reasons for Outsourcing
- Outsourcing Process: Vendor Selection and Management
- Assessing the Strategy & Value of Outsourced Market Research Labor
- Using Automation to Expedite the Delivery of Market Research
- Future Changes in Outsourcing Levels
This crucial research study represents the latest contribution of Best Practices, LLC to the life science industry’s staffing and investment knowledge. While previous studies have captured key metrics to identify optimal resource levels for maximum competitiveness, regulatory and other changes have continued to erode the effectiveness of the industry’s proven business model - a fact pressing executives to reconsider efficient levels of human and capital investment.
This latest study therefore offers an open benchmark opportunity for market research executives throughout the bio-pharma and medical device sectors.
To view or participate in the online survey, follow this link: http://www.surveygizmo.com/s3/800600/Market-Research-Efficiency.
For assistance or questions related to this study, contact research team leader Vahid Sanii at firstname.lastname@example.org or (919) 767-9254. Responses are requested by Mar. 9, 2012.
There is no cost to participate, and all benchmark participants will receive the complete, blinded research results and analysis for free. This study will generate comparative metrics and executive insights that participants can use in the future to help assess what outsourcing levels and automation processes are right for different sizes of company.
BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC’s clients include all the top 10 and 48 of the top 50 global healthcare companies.
The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.